Skip to content
healthcare.dev
Get a free key

INVEGA SUSTENNA

NDC 50458-562, paliperidone palmitate, injection, from Janssen Pharmaceuticals, Inc..

Product NDC
50458-562
Status
Listed
Labeler
Janssen Pharmaceuticals, Inc.
Dosage form
INJECTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022264
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50458-562 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALIPERIDONE PALMITATE117 mg/.75mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
50458-562-01504580562011 SYRINGE in 1 KIT (50458-562-01) / .75 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1af14e42-951d-414d-8564-5d5fce138554

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50458-562

  • NADAC price for package 50458056201

    GET /v1/drugs/nadac/50458056201

Use it

Look up 50458-562 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50458-562 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50458-562. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.